Dicerna Pharmaceuticals reported $1.57B in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acceleron Pharma XLRN:US $ 10.52B 2.9B
Agenus AGEN:US $ 1.22B 2.65M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Arrowhead Research ARWR:US $ 6.51B 2.11B
Biogen BIIB:US $ 42.17B 9.96B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Exelixis EXEL:US $ 6.66B 950.22M
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Immunogen IMGN:US $ 1.18B 139.17M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
Intrexon XON:US $ 1.03B 314.67M
Karyopharm Therapeutics KPTI:US $ 439.39M 335.56M
Lexicon Pharmaceuticals LXRX:US $ 694.92M 32.18M
Macrogenics MGNX:US $ 1.28B 335.6M
Merk MRK:US $ 190131.55M 6786.63M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Pfizer PFE:US $ 241143.67M 21937.97M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Regulus Therapeutics RGLS:US $ 60.11M 810.37K
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M